Bio Engineering Capital

The Medical AI Times is a digital news platform that specializes in covering the latest developments, insights, and analysis in the field of artificial intelligence as it pertains to medicine. The platform, operated by a team of experts, features articles written by doctors and researchers, focusing on AI applications in prevention, treatment, diagnosis, and medical science reports. It aims to provide a comprehensive and up-to-date resource for professionals and enthusiasts interested in the intersection of AI and healthcare.

Revorf is developing innovative diagnostic tools and therapies based on its proprietary gene detection analysis technology. The company focuses on autoimmune diseases, leveraging RNA and protein information analysis along with artificial intelligence to advance drug discovery.